Corporate Investments, Shareholder Returns, and Drug Development Strategy

Exploring the company's initiatives in sustaining growth through capital plans, R&D investments, and developing oral molecules targeting weight management with a focus on co-morbidities. Additionally, touching on reducing debt leverage, returning capital to shareholders, a commitment to a UK listing, and ambitious goals in oncology research.